• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • DeviceTalks Weekly
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

MOTUS GI

Motus GI upsizes follow-on offering

June 27, 2019 By Brad Perriello

Motus GI (NSDQ:MOTS) yesterday upsized a follow-on offering it prepped for late last year to $20 million. Ft. Lauderdale, Fla.-based Motus developed the Pure-Vu device, which is designed to deliver a mixture of water and air to remove debris even when patients haven’t completed their bowel prep for colonoscopies. In February 2018 the company raised […]

Filed Under: Endoscopic, Featured, Funding Roundup, Wall Street Beat Tagged With: MOTUS GI

Zimmer Biomet taps medtech vet Upadhyay for CFO | Personnel Moves June 20 2019

June 20, 2019 By Brad Perriello

Zimmer Biomet (NYSE:ZBH) said yesterday that longtime finance chief Daniel Florin is stepping down effective July 1, to be replaced as CFO by medical device veteran Suketu Upadhyay. Florin is slated to stay on in an advisory capacity “for a period following the succession,” Warsaw, Ind.-based Zimmer said. Upadhyay’s CV includes stints Bristol-Myers Squibb, Endo International, […]

Filed Under: Blog, Business/Financial News Tagged With: becton dickinson, Bentec Medical, German Accelerator Life Sciences, MOTUS GI, Personnel Moves, Zimmer Biomet

Motus GI lands FDA clearance for next-gen colon prep system

June 11, 2019 By Nancy Crotti

Motus GI (NSDQ:MOTS) today announced it has received FDA 510(k) clearance for the second-generation of its Pure-Vu colonoscopy device. Fort Lauderdale, Fla.-based Motus designed the original Pure-Vu device to attach to standard and slim colonoscopes to deliver a mixture of water and air to remove debris when patients haven’t completed their bowel prep. Pure-Vu GEN2 […]

Filed Under: 510(k), Hospital Care, News Well, Regulatory/Compliance Tagged With: MOTUS GI, University of California Irvine

Motus GI preps $14m follow-on

December 20, 2018 By Brad Perriello

Motus GI (NSDQ:MOTS) said yesterday that it’s preparing a follow-on offering worth nearly $14 million for its Pure-Vu colonoscopy device. Ft. Lauderdale, Fla.-based Motus said it plans to float 5 million shares at $2.70 apiece, for gross proceeds of $13.5 million. A 30-day underwriters option on a further 750,000 shares would add $2.0 million if fully […]

Filed Under: Featured, Funding Roundup, Imaging, Wall Street Beat Tagged With: MOTUS GI

Positive PureVu data gives Motus GI a brief bump

October 11, 2018 By Brad Perriello

Motus GI (NSDQ:MOTS) shares got quite a bump yesterday on positive data for its PureVu colonoscopy prep device, before a general market sell-off brought the stock back down to earth. Ft. Lauderdale, Fla.-based Motus GI’s PureVu device is designed to attach to standard and slim colonoscopes to deliver a mixture of water and air to remove debris […]

Filed Under: Clinical Trials, Wall Street Beat Tagged With: MOTUS GI

Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018

September 25, 2018 By Fink Densford

Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]

Filed Under: Business/Financial News Tagged With: Allurion Technologies, Baxter, biomedgps, Bristol-Myers Squibb Co., ConvaTec, Covidien, Integra LifeSciences, Lumicell, Mallinckrodt, MedX Health, MOTUS GI, Myomo Inc, National Institutes of Health (NIH), Natus Medical Inc., northstarmedicaltechnologies, Personnel Moves, Pursuit Vascular, ReWalk Robotics

Motus GI wins FDA nod for Pure-Vu slim colonoscopy sleeve

September 13, 2018 By Fink Densford

Motus GI said today that it won FDA 510(k) clearance for its Pure-Vu slim sleeve as part of its Pure-Vu system, intended for use during slim colonoscopies. With the clearance of the Pure-Vu slim sleeve, Motus GI said that the Pure-Vu system is now cleared for the full range of procedures in the colonoscopy market, with […]

Filed Under: 510(k), Diagnostics, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: MOTUS GI

Motus GI wins CE Mark for Pure-Vu system

March 1, 2018 By Fink Densford

Motus GI said today it won CE Mark approval in the European Union for its flagship Pure-Vu system designed to clean poorly-prepped colons during colonoscopies. Approval was supported by positive results from a 47-patient European clinical study of the Pure-Vu system in cleaning poorly prepared colons, which showed an increase in the number of adequately cleansed […]

Filed Under: Endoscopic, Regulatory/Compliance Tagged With: MOTUS GI

Motus GI closes $18m IPO

February 20, 2018 By Brad Perriello

Motus GI last week closed an initial public offering worth $18 million for its Pure-Vu system for intra-colonoscopy cleaning. Fort Lauderdale-based Motus said it plans to use the proceeds to commercialize Pure-Vu and for R&D, among other things. The company said it sold 3.5 million shares at $5 apiece, grossing $17.5 million, and also granted a 30-day […]

Filed Under: Endoscopic, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: MOTUS GI

Motus GI downsizes IPO to $18m

February 14, 2018 By Fink Densford

Motus GI today priced its upcoming initial public offering, dropping the range from a midpoint of $26 million to a total of $18 million. In the offering, the Fort Lauderdale, Fla.-based company said it will offer 3.5 million shares of common stock at $5 per share, with its shares slated to begin trading on Nasdaq today […]

Filed Under: Business/Financial News, Initial Public Offering (IPO) Tagged With: MOTUS GI

Motus GI sets terms for $26m IPO

February 1, 2018 By Brad Perriello

Motus GI yesterday set the range for its pending initial public offering, which at the midpoint would fetch nearly $26 million. Last month the Israeli company, which makes the Pure-Vu intra-colonoscopy cleaning system, registered the IPO at roughly $28.8 million. Motus GI won FDA clearance for the device in September 2016. Yesterday Motus said it plans […]

Filed Under: Endoscopic, Funding Roundup, Wall Street Beat Tagged With: MOTUS GI

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS